The Protein Myth: Our Obsession With Protein and How It Is Killing US

Houston Methodist

G. Davis

Health of Vegetarians and Vegans: Findings From EPIC-Oxford and Othe…

Physicians Committee for Responsible Medicine

T. J. Key

Medications for Weight Loss: The New Satiety Hormones

Scripps Health

K. Fujioka

The GOOD and the BAD Side of GLP-1s and What to Do If You Get Caught…

Ken Fujioka

Weightloss in Menopause

Susan Brian

Do Triglycerides Cause Heart Disease?

National Lipid Association

I. Goldberg

Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…

University of Colorado Department of Medicine

R. Johnson

SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide

Juan Frias

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

Robert Busch

Labs to Check on Semaglutide or Tirzepatide

Susan Brian

MAFLD: What Is It?

Houston Methodist

D. Victor

Tirzepatide Updates

Diana Isaacs

2025 Trends in Obesity Medicine and GLP-1 Agonists

Amanda Fontenot

The Deadly Paradox: Current Practice, Driven by Guidelines, Is Not A…

Michael Makover

Effects of Low Calorie and Alternative Sweeteners Across the Lifespa…

Keck School of Medicine of USC

M. Goran

Colchicine: Now and What’s Next?

National Lipid Association

C. Ballantyne

The Differences Between the Products of GLP1's and GLP/GIPs

Susan Brian

Metabolic Surgery vs. Pharmacotherapy for Treatment of Obesity

Practical Ways to Achieve Targets in Diabetes Care

S. Nissen

Vitamin D Deficiency

Keck School of Medicine of USC

V. Gevorgyan

Discussing Retatrutide: A GIP, GLP-1, and Glucagon Receptor Agonist

Susan Brian